First Time Loading...

Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 5.66 USD 2.72% Market Closed
Updated: May 20, 2024
Section:
 

Wall Street
Price Targets

FHTX Price Targets Summary
Foghorn Therapeutics Inc.

Wall Street analysts forecast FHTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FHTX is 14.03 USD with a low forecast of 6.06 USD and a high forecast of 21 USD.

FHTX Lowest Forecast
Wall Street Target
6.06 USD
7% Upside
FHTX Average Forecast
Wall Street Target
14.03 USD
148% Upside
FHTX Highest Forecast
Wall Street Target
21 USD
271% Upside
Lowest
Price Target
6.06 USD
7% Upside
Average
Price Target
14.03 USD
148% Upside
Highest
Price Target
21 USD
271% Upside
Foghorn Therapeutics Inc. Competitors:
Price Targets
HPHA
Heidelberg Pharma AG
288% Upside
SNSE
Sensei Biotherapeutics Inc
200% Upside
RPTX
Repare Therapeutics Inc
343% Upside
B
251120
Bio-FD&C Co Ltd
28% Upside
HPHA
Heidelberg Pharma AG
288% Upside
SNSE
Sensei Biotherapeutics Inc
200% Upside
RPTX
Repare Therapeutics Inc
343% Upside
B
251120
Bio-FD&C Co Ltd
28% Upside
CDMO
Avid Bioservices Inc
41% Upside
OVID
Ovid Therapeutics Inc
147% Upside
PRQR
ProQR Therapeutics NV
123% Upside
A
ALVO
Alvotech SA
25% Upside

Revenue
Forecast

Revenue Estimate
Foghorn Therapeutics Inc.

The compound annual growth rate of Foghorn Therapeutics Inc.'s revenue for the next 3 years is 5%.

N/A
Past Growth
5%
Estimated Growth
Estimates Accuracy
-54%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Foghorn Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Foghorn Therapeutics Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
FHTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
FHTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FHTX stock valuation using valuation multiples.
Wall Street Estimates
FHTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FHTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FHTX's stock price target?
Price Target
14.03 USD

According to Wall Street analysts, the average 1-year price target for FHTX is 14.03 USD with a low forecast of 6.06 USD and a high forecast of 21 USD.

What is Foghorn Therapeutics Inc.'s Revenue forecast?
Projected CAGR
5%

The compound annual growth rate of Foghorn Therapeutics Inc.'s revenue for the next 3 years is 5%.

ALPHA SPREAD
Join more than 139,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.